About Leuko
Leuko is developing the first non-invasive white blood cell device. White blood cell assessment is the first-line indicator for various medically relevant situations, ranging from chemotherapy management to the detection of life-threatening infections worldwide.
Founded in 2014 by Alvaro Sanchez-Ferro, Aurelien Bourquard, Carlos Castro Gonzalez and Ian Butterworth.
- Founded
- 2014
- Employees
- 11 to 50
- Total funding
- $12.2M
- Headquarters
- Boston
Leadership
The top of Leuko's org chart, with how many people report into each leader.
Carlos Castro Gonzalez
Co-founder And CEO
9 reports
Ian Butterworth
Cofounder & CTO
3 reports
Aurelien Bourquard
Chief Data Scientist & Cofounder
2 reports
Alvaro Sanchez - Ferro
Cofounder | Chief Medical Officer
1 report
Board
Paul Hartung
Independent Board Member
Amy Salzhauer
Board Member
Marta Gaia Zanchi
Board Member
Jobs at Leuko
No open positions right now. Explore more companies on TheJobsMap.